RAD51 and breast cancer: In accordance with the effect exerted by small molecules targeting Rad51, TNBC BRCAmut BC cells and BCSphCs, bearing the knockdown of SAM68, were sensitive to dinaciclib (Fig. 4F and Supplementary Fig. S4L).